The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.


Updates from The Motley Fool

Latest updates on DURECT from Fool.com.


Stock Performance

DRRX vs. S&P 500 | 2 Year Performance
View Interactive DRRX Charts
Sponsored by

Key Data Points

Primary metrics and data points about DURECT.
Current Price: $1.17
Prev Close: $1.70
Open: $1.20
Bid: $1.15
Ask: $1.16
Day's Range: $1.08 - $1.22
52wk Range: $0.99 - $2.70
Volume: 9,851,125
Avg Vol 714,827
Market Cap: $141.01M
P/E (ttm): -7.39
EPS (ttm): -$0.23
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about DURECT.
CAPS Rating 2 out of 5
 
89 Outperform
12 Underperform
CAPS All Stars
 
25 Outperform
3 Underperform

How do you think DURECT will perform against the market?



You pick for DURECT is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

James E. Brown, CEO

0% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for DURECT.

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers